{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:21:49Z","timestamp":1793845309675,"version":"4.6.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>While adverse events following immunization (AEFI) are frequent, there are limited data on the safety of reimmunizing patients who had a prior AEFI. Our objective was to estimate the rate and severity of AEFI recurrences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We analyzed data from the AEFI passive surveillance system in Quebec, Canada, that collects information on reimmunization of patients who had a prior AEFI. Patients with an initial AEFI reported to the surveillance system between 1998 and 2016 were included. Rate of AEFI recurrence was calculated as number of patients with recurrence\/total number of patients reimmunized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Overall, 1350 patients were reimmunized, of which 59% were 2 years of age or younger. The AEFI recurred in 16% (215\/1350) of patients, of whom 18% (42\/215) rated the recurrence as more severe than the initial AEFI. Large local reactions extending beyond the nearest joint and lasting 4 days or more had the highest recurrence rate (67%, 6\/9). Patients with hypotonic hyporesponsive episodes had the lowest rate of recurrence (2%, 1\/50). Allergic-like events recurred in 12% (76\/659) of patients, but none developed anaphylaxis. Of 33 patients with seizures following measles mumps rubella with\/without varicella vaccine, none had a recurrence. Compared with patients with nonserious AEFIs, those with serious AEFIs were less often reimmunized (60% versus 80%; rate ratio: 0.8; 95% confidence interval: 0.66\u20130.86).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Most patients with a history of mild or moderate AEFI can be safely reimmunized. Additional studies are needed in patients with serious AEFIs who are less likely to be reimmunized.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000002162","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T17:35:18Z","timestamp":1537983318000},"page":"377-383","source":"Crossref","is-referenced-by-count":13,"title":["Rate of Recurrence of Adverse Events Following Immunization"],"prefix":"10.1097","volume":"38","author":[{"given":"Joseline G.","family":"Zafack","sequence":"first","affiliation":[{"name":"Department of Social and Preventive Medicine, Laval University, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Toth","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la sant\u00e9 et des services sociaux du Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Landry","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la sant\u00e9 et des services sociaux du Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Drolet","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec - Universit\u00e9 Laval, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina A.","family":"Top","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Department of Community Health and Epidemiology, Dalhousie University, Halifax, Canada"},{"name":"Canadian Center for Vaccinology, IWK Health Centre, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[{"name":"Department of Social and Preventive Medicine, Laval University, Quebec, Canada"},{"name":"CHU de Qu\u00e9bec - Universit\u00e9 Laval, Qu\u00e9bec, Canada"},{"name":"Direction des risques biologiques et occupationnels, Institut National de Sant\u00e9 Publique du Qu\u00e9bec, Qu\u00e9bec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/pch\/19.6.310","article-title":"Canadian paediatricians\u2019 approaches to managing patients with adverse events following immunization: the role of the Special Immunization Clinic network.","volume":"19","author":"Top","year":"2014","journal-title":"Paediatr Child Health"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0033-3506(05)80476-7","article-title":"Improving immunisation uptake in the United Kingdom.","volume":"104","author":"Baxter","year":"1990","journal-title":"Public Health"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4161\/hv.6.5.11234","article-title":"Referrals to a pediatric immunization service: findings from a practice-based audit of a UK specialist immunization clinic.","volume":"6","author":"Baxter","year":"2010","journal-title":"Hum Vaccin"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"e20163707","DOI":"10.1542\/peds.2016-3707","article-title":"Risk of recurrence of adverse events following immunization: a systematic review.","volume":"140","author":"Zafack","year":"2017","journal-title":"Pediatrics"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamapediatrics.2017.1695","article-title":"Public health and economic consequences of vaccine hesitancy for measles in the United States.","volume":"171","author":"Lo","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jaip.2016.09.048","article-title":"Clinical approach used in medical consultations for allergic-like events following immunization: case series report in relation to practice guidelines.","volume":"5","author":"Zafack","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/j.vaccine.2009.04.020","article-title":"Vaccination-associated anaphylaxis in adults: diagnostic testing ruling out IgE-mediated vaccine allergy.","volume":"27","author":"Seitz","year":"2009","journal-title":"Vaccine"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1097\/INF.0000000000001323","article-title":"Immunizing patients with adverse events after immunization and potential contraindications to immunization: a report from the special immunization clinics network.","volume":"35","author":"Top","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/adc.83.2.128","article-title":"Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service.","volume":"83","author":"Gold","year":"2000","journal-title":"Arch Dis Child"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1824-7288-40-31","article-title":"Vaccine risk assessment in children with a referred reaction to a previous vaccine dose: 2009-2011 retrospective report at the Bambino Gesu\u2019 children hospital, Rome, Italy.","volume":"40","author":"Nicolosi","year":"2014","journal-title":"Ital J Pediatr"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaci.2012.07.019","article-title":"Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE.","volume":"130","author":"Rouleau","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1365-2222.2012.03985.x","article-title":"Vaccine allergy evaluation and management at the specialized Green Channel Consultation Clinic.","volume":"42","author":"Micheletti","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"e20170471","DOI":"10.1542\/peds.2017-0471","article-title":"Allergy testing in children with low-risk penicillin allergy symptoms.","volume":"140","author":"Vyles","year":"2017","journal-title":"Pediatrics"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2008.12.034","article-title":"The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting.","volume":"54","author":"Raja","year":"2009","journal-title":"Ann Emerg Med"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"e160033","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children.","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.acap.2016.11.004","article-title":"Parent-reported penicillin allergy symptoms in the pediatric emergency department.","volume":"17","author":"Vyles","year":"2017","journal-title":"Acad Pediatr"},{"issue":"3 pt 1","key":"R22-20230912","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0091-6749(05)80012-0","article-title":"Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions.","volume":"90","author":"Reisman","year":"1992","journal-title":"J Allergy Clin Immunol"},{"issue":"pt 1","key":"R23-20230912","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/ai.1994.v94.a54889","article-title":"Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis.","volume":"94","author":"van der Linden","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1399-3038.2011.01200.x","article-title":"Risk factors for severe pediatric food anaphylaxis in Italy.","volume":"22","author":"Calvani","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"issue":"pt 1","key":"R25-20230912","first-page":"272","article-title":"Re-sting reactions.","volume":"94","author":"Galatas","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1365-2222.2011.03788.x","article-title":"Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines.","volume":"41","author":"Krishna","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.anai.2015.12.032","article-title":"Natural history of Hymenoptera venom allergy in children not treated with immunotherapy.","volume":"116","author":"Lange","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-016-0120-5","article-title":"International Consensus (ICON): allergic reactions to vaccines.","volume":"9","author":"Dreskin","year":"2016","journal-title":"World Allergy Organ J"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1016\/j.vaccine.2011.03.088","article-title":"Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old.","volume":"29","author":"Quinn","year":"2011","journal-title":"Vaccine"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1542\/peds.2005-2890","article-title":"Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children.","volume":"118","author":"Marshall","year":"2006","journal-title":"Pediatrics"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/INF.0b013e31816591f7","article-title":"Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose.","volume":"27","author":"Rennels","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.vaccine.2006.09.053","article-title":"An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.","volume":"25","author":"Langley","year":"2007","journal-title":"Vaccine"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00063030-200620060-00008","article-title":"Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization.","volume":"20","author":"Frampton","year":"2006","journal-title":"BioDrugs"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.vaccine.2016.12.017","article-title":"Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3-6 years.","volume":"35","author":"Southern","year":"2017","journal-title":"Vaccine"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1542\/peds.106.4.e52","article-title":"Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998.","volume":"106","author":"DuVernoy","year":"2000","journal-title":"Pediatrics"},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/bmj.316.7135.902","article-title":"Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: follow up study.","volume":"316","author":"Vermeer-de Bondt","year":"1998","journal-title":"BMJ"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1440-1754.1999.00419.x","article-title":"Vaccination of children following a previous hypotonic-hyporesponsive episode.","volume":"35","author":"Goodwin","year":"1999","journal-title":"J Paediatr Child Health"},{"key":"R40-20230912","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1016\/j.vaccine.2011.02.044","article-title":"Canadian paediatricians\u2019 opinions on rotavirus vaccination.","volume":"29","author":"Dub\u00e9","year":"2011","journal-title":"Vaccine"},{"key":"R41-20230912","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1016\/j.vaccine.2012.04.100","article-title":"Clinicians\u2019 opinions on new vaccination programs implementation.","volume":"30","author":"Dub\u00e9","year":"2012","journal-title":"Vaccine"},{"key":"R43-20230912","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/cir960","article-title":"Recurrent Guillain-Barre syndrome following vaccination.","volume":"54","author":"Baxter","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201904000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T18:33:17Z","timestamp":1694543597000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201904000-00008"}},"subtitle":["Results of 19 Years of Surveillance In Quebec, Canada"],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002162","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}